CG Oncology, Inc. (CGON)

NMS – Real vaqt narxi. Valyuta: USD

76.99

-0.04 (-0.05%)

Yopilishda: Aug 12, 2026, 4:00 PM EDT

76.99

0.00 (0.00%)

Bozordan keyin: Aug 12, 2026, 4:50 PM EDT

06.08.2026

CG Oncology, Inc. (CGON) Reports Q2 Loss, Misses Revenue Estimates

CG Oncology, Inc. (CGON) came out with a quarterly loss of $0.9 per share versus the Zacks Consensus Estimate of a loss of $0.7. This compares to a loss of $0.54 per share a year ago.

06.08.2026

CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates

DALLAS, Texas, Aug. 06, 2026 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON) today reported financial results for the second quarter ended June 30, 2026, and provided business updates.

Videolar

No Data

There is no data to display

Press-relizlar

06.08.2026

CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates

DALLAS, Texas, Aug. 06, 2026 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON) today reported financial results for the second quarter ended June 30, 2026, and provided business updates.

CG Oncology, Inc. (CGON)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

CG Oncology, Inc. (CGON)

CG Oncology, Inc. (CGON) Reports Q2 Loss, Misses Revenue Estimates

CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates

Videolar

No Data

Press-relizlar

CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates

CG Oncology, Inc. (CGON) Reports Q2 Loss, Misses Revenue Estimates

CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates

Videolar

No Data

Press-relizlar

CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates

Search stocks

CG Oncology, Inc. (CGON)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

CG Oncology, Inc. (CGON)

CG Oncology, Inc. (CGON) Reports Q2 Loss, Misses Revenue Estimates

CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates

Videolar

No Data

Press-relizlar

CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates

CG Oncology, Inc. (CGON) Reports Q2 Loss, Misses Revenue Estimates

CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates

Videolar

No Data

Press-relizlar

CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates